Penn Davis McFarland’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-210,502
| Closed | -$20.9M | – | 53 |
|
2019
Q3 | $20.9M | Sell |
210,502
-1,849
| -0.9% | -$184K | 6.54% | 6 |
|
2019
Q2 | $19.6M | Sell |
212,351
-62
| -0% | -$5.73K | 6.64% | 5 |
|
2019
Q1 | $20M | Sell |
212,413
-3,784
| -2% | -$357K | 6.93% | 5 |
|
2018
Q4 | $13.9M | Buy |
216,197
+36,595
| +20% | +$2.35M | 5.38% | 7 |
|
2018
Q3 | $16.1M | Buy |
179,602
+3,711
| +2% | +$332K | 4.63% | 9 |
|
2018
Q2 | $14M | Buy |
175,891
+143
| +0.1% | +$11.4K | 4.3% | 9 |
|
2018
Q1 | $15.7M | Buy |
175,748
+6,222
| +4% | +$555K | 4.79% | 7 |
|
2017
Q4 | $17.7M | Buy |
169,526
+101,686
| +150% | +$10.6M | 5.18% | 7 |
|
2017
Q3 | $9.89M | Sell |
67,840
-2,301
| -3% | -$336K | 3.06% | 16 |
|
2017
Q2 | $9.11M | Buy |
70,141
+425
| +0.6% | +$55.2K | 2.7% | 19 |
|
2017
Q1 | $8.68M | Buy |
+69,716
| New | +$8.68M | 2.53% | 20 |
|